Prospective observational study on Pazopanib in patients treated for advanced or metastatic renal cell carcinoma in countries in Asia Pacific, North Africa, and Middle East regions: PARACHUTE study

Peer Review reports

Original Submission
20 Apr 2021	Submitted	Original manuscript
Resubmission - Version 2
	Submitted	Manuscript version 2
18 May 2021	Reviewed	Reviewer Report
5 Jun 2021	Reviewed	Reviewer Report
23 Jul 2021	Author responded	Author comments - Ravindran Kanesvaran
Resubmission - Version 3
23 Jul 2021	Submitted	Manuscript version 3
14 Aug 2021	Reviewed	Reviewer Report
Resubmission - Version 4
	Submitted	Manuscript version 4
Publishing
28 Aug 2021	Editorially accepted
14 Sep 2021	Article published	10.1186/s12885-021-08738-z

Back to article page